Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Anderson

Showing results (91-100 of 141) with videos related to

Pageof 15
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 22, 2017
Geographic disparities in donor lung supply and lung transplant waitlist outcomes: A cohort studyLuke J Benvenuto, David R Anderson, Hanyoung P Kim, et al.
Journal of Occupational and Environmental Medicine|August 23, 2020
Influence of Incentive Design and Organizational Characteristics on Wellness Participation and Health OutcomesJessica Grossmeier, David J Mangen, David R Anderson, et al.
Journal of Medicinal Chemistry|May 8, 2007
Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2)David R Anderson, Marvin J Meyers, William F Vernier, et al.
Archives of Internal Medicine|April 13, 2005
A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolismPhilip S Wells, David R Anderson, Marc A Rodger, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2009
Benzothiophene inhibitors of MK2. Part 2: improvements in kinase selectivity and cell potencyDavid R Anderson, Marvin J Meyers, Ravi G Kurumbail, et al.
Echo Research and Practice|August 16, 2019
Application of the Boston Technical Performance Score to intraoperative echocardiographyHannah R Bellsham-Revell, Antigoni Deri, Silvia Caroli, et al.
American Journal of Health Promotion : AJHP|June 3, 2023
Effects of Changing Work Environments on Employer Support for Physical Activity During COVID-19Elizabeth Ablah, Matthew P Buman, Liz Petersen, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 25, 2010
Six-month exercise training program to treat post-thrombotic syndrome: a randomized controlled two-centre trialSusan R Kahn, Ian Shrier, Stan Shapiro, et al.
Plos One|February 2, 2016
MPX-004 and MPX-007: New Pharmacological Tools to Study the Physiology of NMDA Receptors Containing the GluN2A SubunitRobert A Volkmann, Christopher M Fanger, David R Anderson, et al.
Bioorganic & Medicinal Chemistry Letters|June 16, 2007
Novel tetrahydro-beta-carboline-1-carboxylic acids as inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)John I Trujillo, Marvin J Meyers, David R Anderson, et al.
Pageof 15

Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 22, 2017
Geographic disparities in donor lung supply and lung transplant waitlist outcomes: A cohort studyLuke J Benvenuto, David R Anderson, Hanyoung P Kim, et al.
Journal of Occupational and Environmental Medicine|August 23, 2020
Influence of Incentive Design and Organizational Characteristics on Wellness Participation and Health OutcomesJessica Grossmeier, David J Mangen, David R Anderson, et al.
Journal of Medicinal Chemistry|May 8, 2007
Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2)David R Anderson, Marvin J Meyers, William F Vernier, et al.
Archives of Internal Medicine|April 13, 2005
A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolismPhilip S Wells, David R Anderson, Marc A Rodger, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2009
Benzothiophene inhibitors of MK2. Part 2: improvements in kinase selectivity and cell potencyDavid R Anderson, Marvin J Meyers, Ravi G Kurumbail, et al.
Echo Research and Practice|August 16, 2019
Application of the Boston Technical Performance Score to intraoperative echocardiographyHannah R Bellsham-Revell, Antigoni Deri, Silvia Caroli, et al.
American Journal of Health Promotion : AJHP|June 3, 2023
Effects of Changing Work Environments on Employer Support for Physical Activity During COVID-19Elizabeth Ablah, Matthew P Buman, Liz Petersen, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 25, 2010
Six-month exercise training program to treat post-thrombotic syndrome: a randomized controlled two-centre trialSusan R Kahn, Ian Shrier, Stan Shapiro, et al.
Plos One|February 2, 2016
MPX-004 and MPX-007: New Pharmacological Tools to Study the Physiology of NMDA Receptors Containing the GluN2A SubunitRobert A Volkmann, Christopher M Fanger, David R Anderson, et al.
Bioorganic & Medicinal Chemistry Letters|June 16, 2007
Novel tetrahydro-beta-carboline-1-carboxylic acids as inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)John I Trujillo, Marvin J Meyers, David R Anderson, et al.
Pageof 15